Case Report
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jun 6, 2021; 9(16): 4090-4094
Published online Jun 6, 2021. doi: 10.12998/wjcc.v9.i16.4090
Thymosin as a possible therapeutic drug for COVID-19: A case report
Qiong Na Zheng, Mei Yan Xu, Fang Min Gan, Sha Sha Ye, Hui Zhao
Qiong Na Zheng, Mei Yan Xu, Fang Min Gan, Sha Sha Ye, Hui Zhao, Department of Infectious Diseases, The Affiliated Yueqing Hospital, Wenzhou Medical University, Yueqing 325600, Zhejiang Province, China
Author contributions: Zheng QN and Zhao H reviewed the literature and drafted the manuscript; Ye SS drafted all figures; Zheng QN, Xu MY, and Gan FM treated the patient and participated in collecting the data; Zhao H guided the treatment; all authors read and approved the final manuscript.
Supported by The Project for Science and Technology of Wenzhou, No. Y2020278.
Informed consent statement: The patient provided written informed consent for his medical information to be stored and used in the hospital database at the first visit to our center.
Conflict-of-interest statement: The authors declare that they have no competing interests to report.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hui Zhao, MD, Chief Doctor, Department of Infectious Diseases, The Affiliated Yueqing Hospital, Wenzhou Medical University, No. 338 Qingyuan Street, Yueqing 325600, Zhejiang Province, China. 304764851@qq.com
Received: January 22, 2021
Peer-review started: January 22, 2021
First decision: March 25, 2021
Revised: March 28, 2021
Accepted: April 6, 2021
Article in press: April 6, 2021
Published online: June 6, 2021
Processing time: 111 Days and 16.9 Hours
Core Tip

Core Tip: A 51-year-old Chinese man returned from Russia to Yueqing Hospital Affiliated to Wenzhou Medical University on April 27, 2020. He had 2-wk symptoms of chest pain, chest tightness, fatigue, and conscious fever. Oxygen inhalation was given and thymosin was injected twice a week, at 1.6 mg per injection. The patient was successfully treated and discharged after 15 d in the hospital.